Insider Trading Alert: AdvanSource Biomaterials Corp. $ASNB

invest-1346104_1920

AdvanSource Biomaterials Corp. (ASNB) insider have most recently took part in a trading activity. On Aug 23, 2017 Adams Michael F, CEO and President bought 10,000 shares having total worth of $800 at the price of $0.08 per share, following the transaction a total of 609,934 shares owned by Adams Michael F. Before this latest buy, Adams Michael F purchased ASNB at 1 other times during the past twelve months, for a total investment of $700 at an average of $0.07 per share.

The stock has experienced a total of 1 insider trades in the past three months. These trades include 1 buy trades. Furthermore, over the past 12 months , the stock was traded 1 times by insiders. an employee of the company was the buyer in 1 instances.

Time Frame Number of Insider Buy Number of Insider Sell Stock Price Change(%)
3 Month 1 0 60%
12 Month 1 0 -65.63%

Shares of AdvanSource Biomaterials Corp. (ASNB) traded up 14.29% on Aug 24, 2017, hitting $0.09. 2,919 shares of the company’s stock traded hands. AdvanSource Biomaterials Corp. has a 52 week low of $0.04 and a 52 week high of $0.4. The company’s market cap is $0 million.

AdvanSource Biomaterials Corporation, formerly known as CardioTech International, Inc., was founded in 1993 as a subsidiary of PolyMedica Corporation. It develops polymer materials which provide critical characteristics in the design and development of medical devices. Its biomaterials are used in devices that are designed for treating anatomical sites and disease states. Its edge technology, notably products such as ChronoFlex, ChronoSilTM, HydroMed, and HydroThane, has been developed to overcome a design and functional challenges. It also manufactures and sells its proprietary HydroThane polymers to medical device manufacturers that are evaluating HydroThane for use in their products. HydroThane is a thermoplastic, water-absorbing, polyurethane elastomer possessing properties which is suited for the complex requirements of a variety of catheters. In addition to its physical properties, HydroThane exhibits an inherent degree of bacterial resistance, clot resistance and biocompatibility. When hydrated, HydroThane has elastic properties similar to living tissue. The Company also manufactures specialty hydrophilic polyurethanes that are primarily sold to customers as part of exclusive arrangements.

William White

William White is a financial writer. He graduated with a degree in Economics. He has contributed to major financial websites and print publications for over 8 years. He handles much of this site's news coverage for corporate insider activity, and occasionally cover other areas of financial sector.

Latest posts by William White (see all)

About the Author

William White
William White is a financial writer. He graduated with a degree in Economics. He has contributed to major financial websites and print publications for over 8 years. He handles much of this site's news coverage for corporate insider activity, and occasionally cover other areas of financial sector.